Nivolumab plus ipilimumab with chemotherapy as first-line treatment of patients with metastatic non-small-cell lung cancer: final, 6-year outcomes from CheckMate 9LA

Carbone, DP; Ciuleanu, TE; Cobo, M; Schenker, M; Zurawski, B; Menezes, J; Richardet, E; Felip, E; Cheng, Y; Juan-Vidal, O; Alexandru, A; Mizutani, H; Reinmuth, N; Lu, S; Reck, M; John, T; Scherpereel, A; De Marchi, P; Aoyama, T; Sathyanarayana, P; Grootendorst, DJ; Hu, N; Ip, V; Hung, YH; Paz-Ares, LG – 2025 – 10.1016/j.esmoop.2025.105123